DK0700285T3 - Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler - Google Patents

Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler

Info

Publication number
DK0700285T3
DK0700285T3 DK94916318T DK94916318T DK0700285T3 DK 0700285 T3 DK0700285 T3 DK 0700285T3 DK 94916318 T DK94916318 T DK 94916318T DK 94916318 T DK94916318 T DK 94916318T DK 0700285 T3 DK0700285 T3 DK 0700285T3
Authority
DK
Denmark
Prior art keywords
drug
release
alpha
drug delivery
composition
Prior art date
Application number
DK94916318T
Other languages
Danish (da)
English (en)
Inventor
Nidal Farraj
Lisbeth Illum
Peter Watts
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of DK0700285T3 publication Critical patent/DK0700285T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94916318T 1993-05-29 1994-05-27 Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler DK0700285T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939311191A GB9311191D0 (en) 1993-05-29 1993-05-29 Controlled release drug formulation
PCT/GB1994/001158 WO1994027582A1 (en) 1993-05-29 1994-05-27 A drug delivery composition for alpha-adreno receptor blocking agents

Publications (1)

Publication Number Publication Date
DK0700285T3 true DK0700285T3 (da) 1999-02-15

Family

ID=10736382

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916318T DK0700285T3 (da) 1993-05-29 1994-05-27 Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler

Country Status (12)

Country Link
EP (1) EP0700285B1 (de)
JP (1) JPH09504779A (de)
AT (1) ATE171370T1 (de)
AU (1) AU684786B2 (de)
CA (1) CA2163340A1 (de)
DE (1) DE69413534T2 (de)
DK (1) DK0700285T3 (de)
ES (1) ES2124889T3 (de)
FI (1) FI955730A (de)
GB (2) GB9311191D0 (de)
NO (1) NO306759B1 (de)
WO (1) WO1994027582A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
FR2752737B1 (fr) * 1996-08-29 1998-10-02 Synthelabo Comprime a liberation controlee de chlorhydrate d'alfuzosine
JP3797388B2 (ja) * 1996-08-29 2006-07-19 サノフィ−アベンティス アルフゾシン塩酸塩の放出制御錠剤
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
US6749867B2 (en) 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
JPWO2002064120A1 (ja) * 2001-02-13 2004-06-10 大正製薬株式会社 内服ゲル製剤
AU2003278407A1 (en) * 2002-10-22 2004-05-13 Ranbaxy Laboratories Limited Sustained release compositions containing alfuzosin
US8206742B2 (en) 2006-01-12 2012-06-26 Wockhardt Ltd. Sustained release compositions of alfuzosin
US20070292505A1 (en) * 2006-06-15 2007-12-20 Abrika Pharmaceuticals, Inc. Controlled release alfuzosin hydrochloride formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
EP0700285A1 (de) 1996-03-13
EP0700285B1 (de) 1998-09-23
GB9311191D0 (en) 1993-07-14
ES2124889T3 (es) 1999-02-16
DE69413534D1 (de) 1998-10-29
AU684786B2 (en) 1998-01-08
AU6802094A (en) 1994-12-20
JPH09504779A (ja) 1997-05-13
GB9523191D0 (en) 1996-01-17
GB2292315B (en) 1997-04-02
WO1994027582A1 (en) 1994-12-08
NO954583D0 (no) 1995-11-14
ATE171370T1 (de) 1998-10-15
DE69413534T2 (de) 1999-03-18
NO954583L (no) 1995-11-14
FI955730A (fi) 1996-01-26
FI955730A0 (fi) 1995-11-28
CA2163340A1 (en) 1994-12-08
GB2292315A (en) 1996-02-21
NO306759B1 (no) 1999-12-20

Similar Documents

Publication Publication Date Title
DK0817621T4 (da) Farmaceutisk filmdannende sammensætning til transdermal administration
DK0700285T3 (da) Præparat til lægemiddelafgivelse til alfa-adrenoreceptorblokerende midler
PT1028707E (pt) Formulacoes oftalmicas de libertacao controlada contendo medicamentos soluveis em agua
AU1534699A (en) Osmotic dosage form comprising first and second coats
NZ314442A (en) Extended release formulation comprising venlafaxine hydrochloride, film coating composition
PT984774E (pt) Microesferas de libertacao controlada, com retencao gastrica, para uma administracao de drogas melhorada
DE60233898D1 (de) Transdermales therapeutisches system für parkinson-krankheit mit hohen rotigotin-plasmaspiegeln
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
FI954228A (fi) Infuusiolaite hoitoaineen jaksottaista tai jatkuvaa antamista varten
YU36700A (sh) Oralni farmaceutski oblik za doziranje sa produženim oslobađanjem
ATE292453T1 (de) Antivirale arznei
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
HK1060691A1 (en) Ion-strength independent sustained release pharmaceutical formulation
ATE276768T1 (de) Arzneimittel gegen hepatitis
AU2002223970A1 (en) Kyberdrug as autovaccines with immune-regulating effects
DE69615019D1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
AU6869996A (en) Use of esters of polyhydric alcohols to enhance the oral bioavailability of drug substances as well as novel esters and pharmaceutical compositions containing them
PL301249A1 (en) Application of iphosphamide as an anticarcinogenic drug
MX9704847A (es) Material de relleno para forma de dosis farmaceutica de gelatina blanda.
TH35426A (th) สารผสม
HUP9600147A1 (hu) Molsidomint vagy metabolitját tartalmazó transzdermális gyógyszerforma és eljárás annak előállítására
IL115861A0 (en) Pharmaceutical formulation for controlled release of melatonin